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Abstract
Hepatotoxicity is associated with major changes in liver gene expression induced by xenobiotic exposure. Understanding
the underlying mechanisms is critical for its clinical diagnosis and treatment. MicroRNAs are key regulators of gene
expression that control mRNA stability and translation, during normal development and pathology. The canonical technique
to measure gene transcript levels is Real-Time qPCR, which has been successfully modified to determine the levels of
microRNAs as well. However, in order to obtain accurate data in a multi-step method like RT-qPCR, the normalization with
endogenous, stably expressed reference genes is mandatory. Since the expression stability of candidate reference genes
varies greatly depending on experimental factors, the aim of our study was to identify a combination of genes for optimal
normalization of microRNA and mRNA qPCR expression data in experimental models of acute hepatotoxicity. Rats were
treated with four traditional hepatotoxins: acetaminophen, carbon tetrachloride, D-galactosamine and thioacetamide, and
the liver expression levels of two groups of candidate reference genes, one for microRNA and the other for mRNA
normalization, were determined by RT-qPCR in compliance with the MIQE guidelines. In the present study, we report that
traditional reference genes such as U6 spliceosomal RNA, Beta Actin and Glyceraldehyde-3P-dehydrogenase altered their
expression in response to classic hepatotoxins and therefore cannot be used as reference genes in hepatotoxicity studies.
Stability rankings of candidate reference genes, considering only those that did not alter their expression, were determined
using geNorm, NormFinder and BestKeeper software packages. The potential candidates whose measurements were stable
were further tested in different combinations to find the optimal set of reference genes that accurately determine mRNA
and miRNA levels. Finally, the combination of MicroRNA-16/5S Ribosomal RNA and Beta 2 Microglobulin/18S Ribosomal RNA
were validated as optimal reference genes for microRNA and mRNA quantification, respectively, in rat models of acute
hepatotoxicity.
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Introduction
Xenobiotic-induced hepatotoxicity is an important cause of liver
disease whose comprehension depends on the mechanistic studies
of experimental models. The use of whole animals in experimental
toxicity is essential to demonstrate that an agent has an adverse
effect on the liver in a setting of physiological significance [1].
Hepatotoxicity involves an alteration in the expression of
thousands of genes in the liver in response to xenobiotic exposure,
a process that has not yet been fully characterized and understood
[2].
MicroRNAs are small (19–24 nucleotides) RNA molecules that
regulate gene expression at the post-transcriptional level. Micro-
RNAs are known to participate in numerous physiological and
pathological processes and they likely regulate 40% of human
genes. Therefore, there is strong interest in analyzing the
participation of microRNAs in hepatotoxic events [3,4]. Micro-
RNAs typically bind to the 39-UTR of specific ‘target’ mRNAs
[5,6] and interfere with their translation and/or also accelerate the
degradation of the mRNA [7]. Since microRNAs seem to regulate
gene expression by a ‘fine-tuning’ mechanism, the study of the
participation of microRNAs and their targets in specific physio-
logical or pathological experimental situations depends on a
reliable and accurate technique for measuring their expression
levels.
In the past several years, reverse transcription quantitative real-
time polymerase chain reaction (RT-qPCR) has become the
classical technique to measure gene expression due to its accuracy,
sensitivity, specificity, reproducibility and robustness [8–10].
However, RT-qPCR is a multistage process that includes the
extraction of RNA, its reverse transcription and qPCR. Therefore,
a rigorous normalization strategy is required to account for the
resulting technical variability among samples [11]. The use of
reference genes (RGs) as internal controls is the most common
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RG expression levels should be stable across different treatments
or cell types in an experiment. The selection of RGs is not trivial
and previous studies have demonstrated that a single universal RG
is unlikely to exist and perform well for all tissue types or for all
physiological, pathological and experimental situations [11,12].
Moreover, it is highly recommended to use more than one RG in
order to produce more reliable data and also because, in this way,
it is possible to calculate stability parameters to evaluate the
measured RGs in an actual quantification experiment [13].
The identification and validation of the optimal RGs is a crucial
process because they will ultimately be responsible for the
accuracy of the gene expression determinations reported for the
gene of interest. Increasing concern regarding the optimization of
normalization methods that use RGs has led to the development of
several mathematical algorithms, including BestKeeper [14],
geNorm [11] and NormFinder [15], that are aimed at determining
the stability of RGs. Because these algorithms are based on the
assumption that the candidate RGs are not differentially expressed
among groups, the hepatotoxic effects on the relative expression of
each candidate RG must be tested prior to the evaluation of their
stability. The outputs of the different programs can be compared
to obtain a definitive ranking of the RGs using the RankAggreg
package [16]. Then, different combinations of the more stable
RGs are evaluated for the normalization efficiency, using a
strategy that was previously reported [17]. This approach consists
on simulating the expression of a hypothetical gene of interest in
order to asses the accuracy of transcript quantification resulting
with each combination under study. Finally, the selection of the
optimal number of RGs for normalization is carried out taking
into account the trade-off between the improvement in accuracy
and the disadvantage of adding a new gene in the measurement
process.
In this report, we thoroughly analyze and select RGs to
normalize the RT-qPCR expression data of mRNAs and
microRNAs in classical rat models of acute hepatotoxicity. The
hepatotoxins administered were acetaminophen (AA), carbon
tetrachloride (CT), D-galactosamine (GA) and thioacetamide (TA).
We found that several genes that are frequently used to normalize
RT-qPCR data must not be applied as RGs in these models. The
application of several mathematical methods under the experi-
mental conditions revealed that microRNA 16 (miR-16) and 5S
Ribosomal RNA (5S) can be used as RGs for microRNAs
normalization, whereas Beta 2 Microglobulin (B2M) and 18S
Ribosomal RNA (18S) can be used as RGs for the normalization of
mRNA expression data. Our real time qPCR results were
obtained in compliance with the global standardization accords
reflected in the MIQE guidelines and the RMDL language
[18,19].
Results
Assessment of liver injury
The rat models of acute hepatotoxicity for the four hepatotoxins
administered in the dose-response protocol were characterized
evaluating plasma biochemical markers of liver injury and a
histological examination at 24 h post treatment. The alanine
aminotransferase activities of the groups treated with AA, CT, GA
and TA were significantly increased at the highest doses
administered (Figure 1). The changes in the aspartate amino-
transferase activities showed almost the same pattern as the
alanine aminotransferase activities for all groups (data not shown).
A microscopic examination of the livers allowed for the
verification of the injury produced with each hepatotoxin and
the description of their typical histopathological features. Repre-
sentative sections of the livers from the control and the chemically
treated rats 24 h after the highest dosing are shown in Figure 1.
The administration of AA (1.2 g/kg body weight) induced focal
necrosis in the centrilobular region with infiltration of neutrophils
and lymphocytes. The treatment with CT (1 ml/kg body weight)
resulted in moderate to intense hepatocyte necrosis and cytoplas-
mic vacuolization. The animals treated with GA (0.9 g/kg body
weight) presented a mild infiltrate of lymphocytes, macrophages
and neutrophils in the centrilobular region, necrosis and apoptotic
bodies. Lastly, the TA-treated rats (150 mg/kg body weight)
showed a severe infiltration of neutrophils, hepatocyte necrosis and
apoptosis. The studies of RG selection were performed on the
livers of rats treated with the highest doses of each hepatotoxin
comparing to the livers of rats treated with their corresponding
vehicle.
RT-qPCR expression studies of candidate reference genes
The selection of the candidate RGs for microRNAs and for
mRNA was performed using two different set of genes (Table 1).
In the case of microRNA, the evaluated candidate RGs included
5S, miR-16, MicroRNA 103 (miR-103), MicroRNA 191 (miR-191),
MicroRNA Let7a (miR-Let7a), U6 Spliceosomal RNA (U6) and
Small Nucleolar RNA 48 (RNU48). These candidate genes were
selected because they are commonly used as endogenous controls
and/or because of their relative quantities in liver [20–24]. In the
case of the RGs for mRNA normalization, the evaluated genes
were 18S, Beta Actin (ACTB), Albumin (ALB), B2M, Cyclophilin A
(CYCA), Glyceraldehyde-3P Dehidrogenase (GAPDH), Hypoxan-
thine-guanine P-ribosyl Transferase 1 (HPRT1) and Succinate
Dehydrogenase (SDHA), which were selected from the literature
and represent those commonly used as normalizers in liver gene
expression studies [25–29].
The compliance of the RT-qPCR experiments with the MIQE
(Minimum Information for Publication of Quantitative Real-Time
PCR Experiments, [http://www.rdml.org/miqe]) guidelines [18]
is shown in the MIQE checklist (Table S1). All qPCR results
included in this report are available in RDML data format (Real-
time PCR Data Markup Language (RDML) [http://www.rdml.
org]) [19], including the raw microRNA and mRNA expression
data and the experimental and sample annotation files (Data S1).
In the following paragraphs we describe relevant information
related to the RT-qPCR assays that were carried out. 5S 20
[30]miR-16 [31] 21miR-103 [31] 21 miR-191 [31] 21 miR-Let7a
[31] 21 RNU48 [31] 21 U6 22 [32] 18S ACTB 23 [33] ALB 24
[34] B2M 25 [35] CYCA 26 [36] GAPDH HPRT1 27 [26]
SDHA 27 [26]
RNA was purified from liver samples of control rats and rats
treated with the different hepatotoxins. Only high-quality RNA
samples were included in this study, according to the quality
specifications established in the item ‘‘RNA purification’’ of the
Materials and Methods section. The amplification efficiencies for
all evaluated candidate RGs and the genes of interest ranged from
91 to 104% (Table 2), with correlation coefficients of standard
curves ranging from 0.983 to 0.999. Gene-specific amplification
was confirmed by a single peak in the melting-curve analysis and a
single band of the expected size on a 2% agarose gel stained with
ethidium bromide (for a representative trace, see Figure S1).
RT-qPCR was performed to evaluate the expression patterns of
the candidate RGs in the liver of the control rats and the rats
treated with different hepatotoxins (Figure 2). The average
standard deviation within duplicates of all samples studied was
0.10 cycles. The expression levels displayed a wide range of
quantification cycle (Cq) values ranging from 9.82 to 31.06 for the
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MiR-103 and HPRT1 showed relatively low expression
(Cq.28.37), whereas 5S and 18S showed relatively high
expression (Cq,12.45) in both groups of RGs. Comparing the
Cq of the RGs in each group, 5S and 18S showed the least
variability, and U6 and ALB displayed the most variability. As the
5S and 18S transcripts accumulated at high levels, we confirmed
that their expression data were included in the quantitative
dynamic range of our RT-qPCR assays (Figure S2).
Testing for expression differences in reference genes
associated with the exposure to hepatotoxins
The basic requirement of a candidate gene to be used for
normalization purposes is unvarying expression in the respective
study groups. Thus, specific validation is necessary for each
candidate RG prior to its expression stability study. The Student’s
t-test (t-test) was used to compare the log transformation of the
relative quantity of transcript (RQ) of the candidate RG between
the samples from the control and the treated groups for each
hepatotoxin (Figure 3). When the obtained p values were between
0.1 and 0, the experiments were repeated with a new set of animals
to confirm the results (data not shown). Significant differences in
the RQ (p,0.05) with respect to the control groups were observed
for ACTB and GAPDH in the AA-treated livers, for ACTB, ALB,
CYCA and GAPDH in the livers from the TC-treated rats, for U6,
ACTB and CYCA in the livers of the GA group and for U6 and
ACTB in the livers from the TA-treated rats. These altered
expression observed demonstrate that these genes are unsuitable
for the normalization of RT-qPCR data. Therefore, these genes
were excluded from subsequent calculations.
Rank of reference genes according to their expression
stability
From a theoretical perspective, the group of genes, 5S, miR-16,
miR-103, miR-191, miR-Let7a and RNU48, and the group of genes,
18S, B2M, HPRT1 and SDHA, can be used for microRNA and for
mRNA expression data normalization in our models of acute
hepatotoxicity, respectively, because they showed no expression
Figure 1. Liver damage assessment in rat models of acute hepatotoxicity. Plasma alanine aminotransferase (ALT) levels and histological
examination of the livers from rats after 24 h of intraperitoneal administration of acetaminophen (panel A), carbon tetrachloride (panel B), D-
galactosamine (panel C) and thioacetamide (panel D) are shown. The change in the plasma ALT levels in response to increasing doses of each
hepatotoxin was tested by a one-way ANOVA followed by the Newman–Keuls test for multiple comparisons. An asterisk (*) indicates a significant
difference (p,0.05). Representative histological microphotographs of hematoxylin and eosin stained-liver sections after the administration of highest
doses of the hepatotoxins and their respective vehicles (big and small image of each panel, respectively) are shown. The rats were intraperitoneally
administered with: acetaminophen (1.2 g/kg body weight) or its vehicle (1% carboxymethyl cellulose, 10 ml/kg body weight); carbon tetrachloride
(1 ml/kg body weight) or its vehicle (corn oil, 4.4 ml/kg body weight), D-galactosamine (0.9 g/kg body weight) or its vehicle (saline solution, 6 ml/kg
body weight); thioacetamide (150 mg/kg body weight) or its vehicle (saline solution, 6 ml/kg body weight).
doi:10.1371/journal.pone.0036323.g001
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normalization strategy, it is necessary to determine the most stably
expressed gene, i.e., the RGs with minimal biological variance.
Because no unique criterion exists to study this issue, we decided to
apply the three most frequently used programs: BestKeeper,
geNorm and NormFinder. The RankAggreg package was
subsequently used to obtain a definitive stability ranking by
compiling the output of each program.
The results are summarized in Table 3. With BestKeeper, the
stability (SD, standard deviation) and the relationship to the
BestKeeper index (Pearson correlation coefficient r and p values)
are the two most important criteria for evaluating the stability of
RGs. This program uses a pairwise correlation analysis for all pairs
of candidate genes based on the raw Cq values and calculates the
geometric mean of the best suited candidates to establish the
BestKeeper index. Based on the inspection of the SD, Best-Keeper
revealed an overall stability in gene expression (SD,1) for all
candidate genes (Data S2). All RGs, except for RNU48, were
significantly correlated to the BestKeeper index (p,0.05). The
Pearson correlation coefficient of each gene gave the highest
stability expression to miR-16 and miR-191 for microRNA studies
and SDHA and 18S for mRNA studies (Data S2).
The geNorm program calculates the M stability value of a gene
based on the average pairwise variation between all studied genes.
A high gene expression variability results in high M values and
indicates low expression stability. The M values of the evaluated
genes were all under 1.5, which indicates that the expressions of
the different candidate genes are relatively stable. The highest-
ranked genes were miR-16 and 5S for microRNA and B2M and
18S for mRNA expression studies (Data S2).
NormFinder employs a model-based approach that, in addition
to the overall expression level variation, also takes into account the
intra- and intergroup variation of the candidate normalization
genes to evaluate the expression stability. Using NormFinder, the
top-ranked RGs were miR-16 and 5S in the group of candidate
RGs for microRNA and B2M and 18S in the group of candidate
RGs for mRNA (Data S2).
A comparison of the rankings produced by the three approaches
revealed differences as a consequence of the different algorithms
used by each program (Table 3). The stability measurements
produced by geNorm, NormFinder and BestKeeper were
combined to establish a consensus rank of the genes applying
the RankAggreg package. Specifically, the BruteAggreg function
of this package performs an aggregation of ordered lists based on
the ranks using a brute-force algorithm, i.e. generating all possible
ordered lists and finding the list with the minimum value of the
objective function. To generate all possible ordered lists, the
permutation function from the tool package was used, and an
unweighted rank aggregation was performed. We were able to use
this function because we had a number of candidate RGs less than
10 in both cases. The input for this statistical package was a matrix
of rank-ordered genes according to the different stability
measurements previously computed. Because geNorm gives the
same M stability value for the two most stable genes, two
consensus lists of RGs were constructed, altering the position of the
two most stable genes in the geNorm list. The Spearman footrule
function was applied to calculate the ‘‘distance’’ among ordered
lists. If the two possible analyses (with each one of the geNorm
possibility) results in different rankings, the consensus ranking with
the lowest score was chosen. Subsequently, using the BruteAggreg
function, the top-ranked genes were miR-16, 5S and miR-Let7a in
the group of candidate RGs for microRNA and B2M, 18S and
SDHA in the group of candidate RGs for mRNA (Data S2).
Table 1. Descriptions of selected candidate reference genes and genes of interest.
Gen Symbol Gene Name GenBank or miRbase Acc. N6 Gene Function
Candidate reference genes for microRNA normalization
5S 5S Ribosomal RNA K01594.1 Protein synthesis
miR-16 MicroRNA 16 MI0000844 Regulation of apoptosis
miR-103 MicroRNA 103 MI0000888 Regulation of neuroblastoma cell migration
miR-191 MicroRNA 191 MI0000934 No functionally verified targets
miR-Let7a MicroRNA Let7a MI0000827 Regulation of cell proliferation
RNU48 Small Nucleolar RNA 48 X96648.1 Modification of small nuclear RNAs
U6 U6 Spliceosomal RNA K00784.1 RNA Splicing
Candidate reference genes for mRNA normalization
18S 18S Ribosomal RNA V01270 Protein Synthesis
ACTB Beta Actin NM_031144.2 Cytoskeletal structural protein
ALB Albumin NM_134326.2 Major plasma protein
B2M Beta 2 Microglobulin NM_012512.1 Beta-chain of major histocompatibility complex
CYCA Cyclophilin A M19533.1 Serine-threonine phosphatase inhibitor
GAPDH Glyceraldehyde-3P-dehidrogenase NM_017008.3 Glycolysis pathway enzyme
HPRT1 Hypoxanthine-guanine P-ribosyl transferase 1 NM_012583.2 Metabolic salvage of purines
SDHA Succinate Dehydrogenase NM_130428.1 TCA pathway enzyme
Genes of interest
miR-122 MIcroRNA 122 MI000891 Regulation of lipid metabolism
CCNG1 Cyclin G1 NM_012923.2 Cellular growth
doi:10.1371/journal.pone.0036323.t001
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(6C) E (%) Ref
Candidate reference genes for microRNA normalization
5S RT: AGCCTACAGCACCCGGTATT 40 81.6 94 [30]
F: GCCCGATCTTGTCTGATCTC
R: CCTGACCCTGCTTAGCTTCC
miR-16 RT: GTCTCCTCTGGTGCAGGGTCCGAGGTATTCGCACCAGAGGAGACCGCCAA 50 83.5 91 [31]
F: CAGCCTAGCAGCACGTAAAT
R: GAGGTATTCGCACCAGAGGA
miR-103 RT: GTCTCCTCTGGTGCAGGGTCCGAGGTATTCGCACCAGAGGAGACTCATAG 51 79.8 104 [31]
F: TACGCAGCAGCATTGTACAG
R: GAGGTATTCGCACCAGAGGA
miR-191 RT: GTCTCCTCTGGTGCAGGGTCCGAGGTATTCGCACCAGAGGAGACCAGCTG 49 80.0 104 [31]
F: CACCAACGGAATCCCAAA
R: GAGGTATTCGCACCAGAGGA
miR-Let7a RT: GTCTCCTCTGGTGCAGGGTCCGAGGTATTCGCACCAGAGGAGACAACTAT 50 81.5 96 [31]
F: CGCGCTGAGGTAGTAGGTTG
R: GAGGTATTCGCACCAGAGGA
RNU48 RT: GTCTCCTCTGGTGCAGGGTCCGAGGTATTCGCACCAGAGGAGACGGTCAG 65 88.5 93 [31]
F: TCTGAGTGTCTTCGCTGACG
R: GAGGTATTCGCACCAGAGGA
U6 RT: AACGCTTCACGAATTTGCGT 93 85.7 94 [32]
F: CTCGCTTCGGCAGCACA
R: AACGCTTCACGAATTTGCGT
Candidate reference genes for mRNA normalization
18S RT: GAGCTGGAATTACCGCGGCT 159 87.8 97 a
F: AAACGGCTACCACATCCAAG
R: TTGCCCTCCAATGGATCCT
ACTB F: ATTGCTGACAGGATGCAGAA 109 86.7 104 [33]
R: TAGAGCCACCAATCCACACAG
ALB F: GATGCCGTGAAAGAGAAAGC 196 89.2 93 [34]
R: CGTGACAGCACTCCTTGTTG
B2M F: ACATCCTGGCTCACACTGAA 109 87.1 94 [35]
R: ATGTCTCGGTCCCAGGTG
CYCA F: AGCACTGGGGAGAAAGGATT 248 87.8 97 [36]
R: AGCCACTCAGTCTTGGCAGT
GAPDH F: GTATCGGACGCCTGGTTAC 128 87.1 93 a
R: CTTGCCGTGGGTAGAGTCAT
HPRT1 F: GCTGAAGATTTGGAAAAGGTG 157 87.7 92 [26]
R: AATCCAGCAGGTCAGCAAAG
SDHA F: AGACGTTTGACAGGGGAATG 160 89.8 97 [26]
R: TCATCAATCCGCACCTTGTA
Genes of interest
miR-122 RT: GTCTCCTCTGGTGCAGGGTCCGAGGTATTCGCACCAGAGGAGACCAAACA 50 83.4 97 [31]
F: GGCTGTGGAGTGTGACAATG
R: GAGGTATTCGCACCAGAGGA
CCNG1 F: AGTCTTAAGGGACGTCAGGAG 119 86.1 92 a
R: GCTGAGGAGCTACCCACATT
Am: amplicon size. bp: numer of base pairs. E: Assay efficiency. Tm: melting temperature. Ref: references. RT: retro-transcription primer. R: Reverse primer. F: Forward
primer. a: Primers were designed using Primer3 software.
doi:10.1371/journal.pone.0036323.t002
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The optimal number of RGs was determined evaluating the
normalization efficiency resulting of adding RGs stepwise
according to the stability ranking. The evaluation of the
normalization efficiency involves the estimation of the accuracy
in the quantification of a hypothetical gene of interest through the
determination of the minimum expression difference detectable
between experimental groups for each combination of RGs. The
expression of the hypothetical gene is simulated in the control and
the treated groups so that, after the arbitrary expression value is
normalized with a specific combination of RGs, the minimal
statistically significant difference that could be observed between
them can be determined. Although our simulation of expression
levels for the hypothetical gene of interest did not include any
variability among biological samples belonging to the same
experimental group, this strategy results very useful to compare
the different normalizers. In order to simplify the application and
interpretation of the method to determine the number of RGs
described in this paragraph, we defined a new parameter named
the normalization efficiency index (NEI). This value is the
minimum fold change (for up- or down-regulation) in the
normalized relative quantity of transcript (NRQ) of a hypothetical
gene of interest that gives statistically significant differences with
the t-test (p,0.05), using the candidate RGs under study. The
lower the NEI value is, the more efficient is the normalization
method evaluated, considering the up- or down-regulation in one
toxin-treated group. In our case, we calculated the average NEI
value (including the NEI values for AA, CT, GA and TA) for
situations of up- and down-regulation and used it to evaluate the
different normalization methods and to establish the optimal
number of RGs to be used. Figure 4 shows that, when considering
the normalization method with only one RG, miR-16 and B2M are
the most efficient normalizers for their respective microRNA and
mRNA RG groups. This similar tendency is observed when the
NEI value is analyzed for each individual hepatotoxin (Figure S3).
The use of two or more RGs as normalizers has been highly
recommended because the use of multiple RGs allows for the
evaluation of the stability of these RGs in each experiment [13].
The definition of the number of genes to be used for normalization
(beginning from two) must involve the valuation of the trade-off
between the benefits in accuracy when introducing a new RG and
the increased labor and costs of the experiment. From the data
displayed in Figure 4 it can be seen that the use of three or more
RGs does not introduce any significant advantage in the
Figure 2. Boxplot of RT-qPCR quantification cycles values of candidate reference genes. Boxplot of quantification cycles (Cq) values for
each reference gene for microRNA and mRNA normalization in all liver samples assessed (n=35) which belong to rats treated with each one of the
four hepatotoxins studied and their respective control animals administered with vehicle. A line across the box depicts the median. The box indicates
the 25% and 75% percentiles. Whiskers represent the maximum and minimum values, circles represent outliers. The livers were evaluated 24 h after
rats were intraperitoneally administered with: acetaminophen (1.2 g/kg body weight) or its vehicle (1% carboxymethyl cellulose, 10 ml/kg body
weight); carbon tetrachloride (1 ml/kg body weight) or its vehicle (corn oil, 4.4 ml/kg body weight), D-galactosamine (0.9 g/kg body weight) or its
vehicle (saline solution, 6 ml/kg body weight); thioacetamide (150 mg/kg body weight) or its vehicle (saline solution, 6 ml/kg body weight).
doi:10.1371/journal.pone.0036323.g002
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groups of RGs, considering both senses of modification. An
evaluation of the NEI values for the individual treatments
demonstrates that the inclusion of a third RG does not lead to a
normalization improvement in any of the four studied hepatotox-
ins, considering both groups of RGs (Figure S3). Therefore, we
Figure 3. Effect of rat exposure to hepatotoxins on liver expressions of candidate reference genes. The expression of candidate
reference genes for microRNA and mRNA normalization in the liver of rats treated with the hepatotoxins and their respective vehicles are shown. The
livers were evaluated 24 h after rats were intraperitoneally administered with: acetaminophen (AA, 1.2 g/kg body weight) or its vehicle (1%
carboxymethyl cellulose, 10 ml/kg body weight); carbon tetrachloride (CT, 1 ml/kg body weight) or its vehicle (corn oil, 4.4 ml/kg body weight), D-
galactosamine (GA, 0.9 g/kg body weight) or its vehicle (saline solution, 6 ml/kg body weight); thioacetamide (TA, 150 mg/kg body weight) or its
vehicle (saline solution, 6 ml/kg body weight). The bars represent the means of the relative quantity of transcript 6 SD of 5 animals treated with
hepatotoxins or their respective vehicle. An asterisk (*) indicates a significant expression difference with p,0.05 using Student’s t-test of the log-
transformed data between the control and treated groups.
doi:10.1371/journal.pone.0036323.g003
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and mRNA expression normalization data, respectively.
Vandesompele et al. [11] defined a variable ‘‘V’’ that is used to
evaluate the improvement of the normalization method that
results from the sequential addition of RGs. ‘‘Vn/n+1’’ represents
the pairwise variation in the normalization factor for n RGs and
the normalization factor of n+1 RGs. As a consequence, it reflects
the effect of the normalization factor stability with the inclusion of
an additional gene. According to the original publication of the
geNorm developers, the additional RG included is considered not
to improve the normalization accuracy significantly if the pairwise
variation resulting from the evaluation of n genes and n+1 genes is
below a cut-off value of 0.15. If we apply this parameter in our
resulting consensus rank stability of candidate RGs for microRNA,
the pairwise variation calculations are V2/3=0.114, V3/4=0.122,
V4/5=0.085 and V5/6=0.080. We found a complete coincidence
between the two criteria, indicating that two RGs, miR-16 and 5S,
are the best normalizers for microRNA expression studies. In the
case of the candidate RGs for mRNA, we observed a discrepancy
in the number of recommended genes. Considering the V value
criterion, the use of three RGs is recommended (V2/3=0.174 and
V3/4=0.140). However, taking into account that others have
reported that there was no significant improvement with the
addition of a new RG with ‘‘V’’ values even more than 0.20 [37–
40] and also considering the technical and economic advantages of
using one less RG, we confirm the recommendation of using B2M
and 18S as the selected mRNA normalization method.
Confirmation of the altered expression of candidate
reference genes. To confirm the alteration of the candidate
RGs in the treated rat livers reported above, we normalized their
RQ levels using the method validated in this report. The
normalization factor was calculated as the geometric mean of
the combination of two genes (miR-16/5S for microRNAs and
B2M/18S for mRNAs). The statistical significance of the
differential log-transformed expression levels between the groups
was assessed by the t-test with a p,0.05. The NRQ value of each
gene is presented as mean 6 SD (n=5). The NRQ of U6
diminished in the livers of the rats treated with GA with respect to
the vehicle-treated rats (C 1.0060.16 vs. GA 0.4260.04,
p,0.001) and increased in the livers of the rats treated with TA
(C 1.0060.05 vs. TA 1.4560.21, p,0.001). With respect to the
candidate RGs for mRNA studies, we observed an increased NRQ
of ACTB in the liver of AA-treated rats (C 1.0060.17 vs. AA
1.8460.78, p,0.05), in the liver of CT-treated rats (C 1.0060.10
vs. CT 1.7460.45, p,0.001), in the liver of GA-treated rats (C
1.0060.17 vs. GA 1.8660.31, p,0.001), and in the liver of TA-
treated rats (C 1.0060.29 vs. TA 2.5660.43, p,0.001). ALB was
another candidate RG evaluated that showed a markedly altered
NRQ in the livers of the rats treated with CT (C 1.0060.22 vs.
CT 0.3560.07, p,0.001), whereas such NRQ changes were
observed for CYCA in the livers of the CT-treated rats (C
1.0060.14 vs. CT 1.9960.31, p,0.001) and the GA-treated rats
(C 1.0060.09 vs. GA 0.6260.21, p,0.05). Lastly, GAPDH showed
an increased expression level in the livers of the rats treated with
AA (C 1.0060.34 vs. AA 2.5560.74, p,0.005) and with CT (C
1.0060.16 vs. CT 1.6460.36, p,0.005). To test the quality of
these expression studies, the values of the parameter M
(introduced in the geNorm program description), and the
coefficient of variation of the NRQs of the RGs were calculated
for all of the experiments presented in this section; the results in all
cases were lower than the cut-off values (0.5 and 25%, respectively)
established in a previous report [13].
Evaluation of genes of interest expression during acute
hepatotoxicity
Previous microarray analysis have shown that MicroRNA 122
(miR-122) diminishes its expression in AA-treated mouse livers
24 hours after toxic administration [41]. In order to evaluate some
of the normalization methods analyzed in this report, we studied
the liver expression of miR-122 and its validated mRNA target,
Cyclin G1 (CCNG1) [42], in AA treated rats, using the same
experimental design used to confirm the altered expression of
RGs.
We determined the expression level of miR-122 by RT-qPCR
using the two selected RGs (miR-16/5S) in the liver of AA-treated
rats and, as expected, we observed a decrease in miR-122 levels (C
1.0060.18 vs. AA 0.6260.16, p,0.01). When we normalized the
miR-122 expression levels using RNU48, a candidate microRNA
RG with a lower expression stability, we still observed a significant
change in AA-treated rats (C 1.0060.24 vs. AA 0.4960.21,
p,0.01). However, there is a loss in accuracy of the normalization,
evidenced by the increase in the standard deviation, showing that
miR-16/5S performed better than RNU48. These differences in
the efficiency of normalization using the miR-16/5S combination
or RNU48 are in agreement with the previous analysis using the
NEI. Furthermore, considering that the analysis using an
hypothetical gene of interest is more specific because it does not
include the intra-groups variability intrinsic of a real gene, the NEI
value provides an advantage in the evaluation of normalization
methods.
When we used the two RGs that we selected, B2M/18S, as
normalization method to study the CCNG1 transcript levels in
livers of AA-treated rats, we observed a significant increase (C
1.0060.26 vs. AA 1.9560.67, p,0.01). This observation is in
accordance with the diminished expression of its negative
regulator miR-122 in AA-treated livers and is in agreement with
previous data showing an inverse correlation between miR-122
and CCNG1 expression [42]. Interestingly, the normalized liver
expression levels of CCNG1 would not have changed if the RGs
used were ACTB (C 1.0060.36 vs. AA 0.9960.56, p,0.386) or
GAPDH (C 1.0060.30 vs. AA 1.2960.78, p,0.253). These
Table 3. Ranking of candidate reference genes according to
their stability value.
Stability order Bestkeeper geNorm NormFinder Consensus
Candidate reference genes for microRNA normalization
1 miR-16 miR-16/5S miR-16 miR-16
2 miR-191 5S 5S
3 5S miR-Let7a miR-Let7a miR-Let7a
4 miR-103 miR-191 miR-191 miR-191
5 miR-Let7a miR-103 miR-103 miR-103
6 RNU48 RNU48 RNU48 RNU48
Candidate reference genes for mRNA normalization
1 SDHA B2M/18S B2M B2M
2 18S 18S 18S
3 B2M SDHA SDHA SDHA
4 HPRT1 HPRT1 HPRT1 HPRT1
Each column refers to a gene stability ranking computed by one statistical tool,
using all gene expression values measured for each candidate reference gene.
The stability measurements produced by geNorm, NormFinder and BestKeeper
were combined to establish a consensus rank of the genes applying the
RankAggreg package.
doi:10.1371/journal.pone.0036323.t003
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PLoS ONE | www.plosone.org 8 May 2012 | Volume 7 | Issue 5 | e36323Figure 4. Study of the normalization efficiency of candidate reference genes. The average normalization efficiency index (NEI) of the four
treatments for each microRNA or mRNA normalization method and their corresponding standard deviation are shown in up- and down-regulation
situations. For each treatment with a specific hepatotoxin, we defined the NEI value as the minimum fold up- or down-regulation of the simulated
expression of a hypothetical gene needed to observe a significant difference (t test, p=0.05, n=5) using different methods of normalization. The liver
expression value of one or combination of reference genes (RGs) was used to normalize the expression of the hypothetical gene. The liver expression
of RGs were assessed 24 h after rats were intraperitoneally administered with: acetaminophen (AA, 1.2 g/kg body weight) or its vehicle (1%
carboxymethyl cellulose, 10 ml/kg body weight); carbon tetrachloride (CT, 1 ml/kg body weight) or its vehicle (corn oil, 4.4 ml/kg body weight), D-
galactosamine (GA, 0.9 g/kg body weight) or its vehicle (saline solution, 6 ml/kg body weight); thioacetamide (TA, 150 mg/kg body weight) or its
vehicle (saline solution, 6 ml/kg body weight).
doi:10.1371/journal.pone.0036323.g004
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experiments to evaluate the possible alteration of candidate RGs
expression levels between the groups under study.
Discussion
The relative quantification of gene expression by Real-Time
qPCR has become one of the major methods for studying
microRNA and mRNA levels in tissues or cell cultures. However,
the performance of this technique is strongly dependent on an
adequate normalization strategy through the selection of stably
expressed RGs. It has been demonstrated that classical RGs
altered their expression under different experimental situations
[11,12]. This is the first report where suitable RGs for expression
studies of microRNAs and mRNAs are identified in rat models of
acute hepatotoxicity.
AA, CT, GA and TA are standard hepatotoxins used in
experimental toxicity studies for the elucidation of the general
mechanisms of liver injury and compensatory tissue repair, testing
hepatoprotective treatments and identifying potential biomarkers
[1,43]. The validation of the acute hepatotoxicity models through
the verification of the damaged induced is in accordance with the
classical reports. In our case, we confirmed the liver responses to
the exposure of the hepatotoxins (AA, CT, GA and TA) through
doses-response studies evaluating the plasma transaminase levels
and histopathology examination.
In these rat acute hepatotoxicity models, we selected the optimal
RGs according to an analysis of five steps: 1) the selection of the
candidate RGs to be evaluated; 2) gene expression measurement
by RT-qPCR; 3) the exclusion of the candidate RGs that modify
their expression in the experimental setting; 4) the establishment of
the expression stability ranking within the remaining group of
RGs; and 5) the determination of the number of RGs to be used
(Figure 5). Although there are precedents from different reports
that use some of these steps, our complete workflow represents an
original strategy to select RGs in different experimental designs
and models. Some of the statistics tests used in this study (e.g., the
t-test and Pearson correlation analyses of BestKeeper) require
normally distributed data. Specifically, the qPCR data (RQ and
NRQ scale) are nonlinear, and they typically suffer from a
heterogeneity of variance across biological replicates, both within
treatments and across treatments, which can usually be accounted
for applying a log transformation [14,44]. We confirmed this
assertion in our experimental setting verifying the assumption of
the normality of the log-transformed dataset of the RQ level of the
RGs (for the microRNA and mRNA normalization) that do not
modify their expression by the Shapiro-Wilk test (Table S2).
All candidate RGs for microRNA and mRNA normalization
were selected based on their known expression in liver tissues, on
previous uses as RGs in liver studies and considering that they
belong to different functional classes to reduce the chance that the
genes might be co-regulated. The demonstration that the
candidate RGs do not exhibit modified RQ levels in the livers of
the rats treated with hepatotoxins was validated using the t-test.
We observed a modification of RQ expression in ALB, CYCA and
GAPDH in the CT-treated rats, a change in GAPDH RQ
expression in the rats treated with AA, an RQ alteration of U6
and CYCA in the GA-group, a change in the RQ of U6 in the TA-
group and, lastly, a modified ACTB expression in the livers of all
treated groups. All these results were further confirmed testing the
statistically significant differences in the NRQ values that were
calculated using the optimal RGs proposed in this report as
normalizers.
Previous hepatotoxicity studies have described similar alter-
ations of GAPDH and ACTB associated to AA and CT exposure,
respectively. Heinloth et al. [45] found a significant up-regulation
of GAPDH expression following the 24 and 48 h exposure of rats to
a high dose of AA (1500 mg/kg). Additionally, Armendariz-
Borunda et al [46] found an approximately two fold increase in the
ACTB transcript 24 h after CT treatment in rats. These
agreements indicate that the liver cells in our experimental setting
are responding to the exposure of the hepatotoxins at the level of
gene expression. Therefore, this represents another important
validation of our models of acute hepatotoxicity, together with the
impairment of plasma toxicity markers and the histological
damaged observed.
The use of RGs in the normalization procedure that display
modifications in their expression between experimental groups
could result in serious errors in gene expression studies, which
could lead to incorrect conclusions. Despite this, only few previous
reports have evaluated this possibility [26,38,47–49]. In this study,
several candidate RGs (among them, the conventional GAPDH
and ACTB) showed altered expression in the acute hepatotoxicity
models studied. A similar situation was found in different studies
evaluating candidate RGs for mRNA normalization: in a
cytotoxicity study using AA [49] and in dioxin-treated rats [26],
it was observed that about 40 and 50% of the candidate RGs
changed their expressions in response to the hepatotoxin,
respectively. These findings highlight the importance of testing
the alteration of expression of RGs in toxicity studies.
The overall expression stability is a further major criterion in
the selection of the best candidate RG. Different algorithms
specifically developed for RGs evaluation and selection were used,
e.g., based on repeated RG pairwise correlation and regression
analysis [14], ranking and stepwise elimination of the least stable
gene [11], or statistical linear mixed-effects modeling [15] of the
respective experimental data. Altogether, there were strong
similarities among the different programs, but the coincidence in
assigning the genes with the highest and lowest score was not
absolute. The different rankings generated by the three software
packages were compared to obtain a consensus stability order of
the RGs using the RankAggreg package of R project [16]. The
RankAggreg package has the ability to combine lists obtained from
different sources, which may not otherwise be directly comparable;
recently, it was introduced to compare the output of RG selection
software [50]. In this study, we were able to produce the consensus
list provided in Table 3.
An efficient normalization methodology enables the gathering
of reproducible and biologically relevant RT-qPCR data correct-
ing non-biological sample-to-sample variations that could be
introduced by protocol-dependent inconsistencies. Ideally, the
main source of variability in gene expression that is observed is a
consequence of the treatment applied to the samples, resulting in
the possibility of detecting smaller biologically induced differences
through statistical analyses. We defined the NEI value as the
minimum fold up- or down-regulation of the NRQ needed to
observe a significant difference (t-test, p=0.05) using a particular
normalization method (a specific combination of RGs in both
number and identity) in a specific hepatotoxin treatment (AA or
CT or GA or TA). Strategies using the normalization of a
simulated hypothetical gene expression dataset to evaluate
normalization methods were used in previous reports [17]. When
we analyzed the ranking of RGs according to both their stability
(Table 3) and their average NEI value for up- and down-regulation
when the normalization is to a single RG (Figure 4), we observed
the lowest NEI values for the best ranked RGs on the expression-
stability scale and the highest NEI values for the least stable RGs.
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evaluate the stability of the putative RGs.
The minimum number of RGs recommended to use in a
normalization method is two, as it is possible to obtain more
accurate data and to test the stability of the chosen RGs in an
actual quantification experiment [13]. When we analyze the
efficiency of normalization with RGs added stepwise through the
NEI value and the parameter V defined by Vandesompele et al.
[11], we obtain similar results, further supporting the method
proposed in this report for assigning the optimal number of RGs to
be considered for normalization. Interestingly, Figure 4 clearly
demonstrates that the use of two or more RGs is a more efficient
normalization method than using individual RGs, and this
affirmation is more evident in the average NEI values of the less
stable RGs. In this report, we propose the use of miR-16/5S and
B2M/18S as the normalizers of microRNA and mRNA liver
expression in rat models of acute hepatotoxicity. Each of the RGs
in both pairs of genes belongs to differents biological classes and
present different physiological functions in the liver.
Lastly, through the comparative evaluation of the analysis of
putative RGs for both microRNA and mRNA normalization, it is
clear that microRNA expression studies have certain advantages
over mRNA in these models of acute hepatotoxicity. First, in the
mRNA group, several genes were discarded because they
exhibited altered expression between the control and the treated
groups. The observation of the expression stability output values,
i.e., SD, M or stability for each program is linked to this difference.
It is also clear that candidate RGs for microRNA are more stably
expressed than candidate RGs for mRNA expression studies. This
difference is confirmed by the lower NEI values for the microRNA
RGs compared to those of the mRNA RGs. These results confirm
the importance of RG selection, especially in mRNA studies.
In conclusion, we present the first experimentally validated
comparison of RGs for the normalization of microRNA and
mRNA qPCR expression data in rat models of acute hepatotox-
icity. The study was developed following an original workflow,
where the confirmation of altered expression due to treatment is
demonstrated to be a main issue in hepatotoxicity models. The
combined use of miR-16/5S and B2M/18S were validated as the
optimal normalization method for microRNA and mRNA
expression data from liver, respectively, in rat models of acute
hepatotoxicity. Therefore, the normalization methods proposed in
this report will contribute to improve studies on the mechanism of




All experiments with animals were performed according to the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the School of Biochemical and Pharma-
ceutical Sciences, National University of Rosario, Argentina (Res.
(CD) Nu 267/020). The protocols were approved by the Animal
Care and Use Committee of the School of Biochemical and
Pharmaceutical Sciences, and included in a Research project
Figure 5. Workflow for reference gene selection. All the steps (S+number) followed for reference gene selection in this report are shown. The
strategy (S) applied and the tools (T) used in each step are mentioned in each corresponding panel.
doi:10.1371/journal.pone.0036323.g005
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(BIO226, Res. (CS) Nu 544/2009).
Animals and chemicals employed
Adult male Wistar rats (300–350 g; School of Biochemical and
Pharmaceutical Sciences, National University of Rosario) were
used in the study. The animals were provided a standard diet and
water ad libitum and housed in a temperature (21–23uC)- and
humidity (45–50%)-controlled room under a constant 12 h light,
12 h dark cycle. All animals received humane care, according to
the Guide for the Care and Use of Laboratory Animals (School of
Biochemical and Pharmaceutical Sciences, National University of
Rosario, Argentina) and the protocols were approved by the
Animal Care and Use Committee of the School of Biochemical
and Pharmaceutical Sciences. The hepatotoxins, AA, CT, GA and
TA, were purchased from Sigma Chemical Co. (St. Louis, MO,
USA).
Assessment of liver injury. Different animals received a
unique intraperitoneal injection of vehicle and different doses of
each hepatotoxin under study. The animals were sacrificed 24 h
later. The dosages of each chemical compound administered were
as follows: AA (0.3, 0.6 and 1.2 g/kg body weight; n=5); CT (0.1,
0.4 and 1 ml/kg body weight; n=5); GA (0.2, 0.5 and 0.9 g/kg
body weight; n=5) and TA (10, 50 and 150 mg/kg body weight;
n=5). The vehicles used for each xenobiotic were: 1% CMC
(carboxymethyl cellulose, 10 ml/kg body weight, AA); corn oil
(4.4 ml/kg body weight, CT) and saline solution (6 ml/kg body
weight, GA and TA). Based on our dose-response curve analysis,
we decided to study the selection of RGs in the livers of rats treated
with the highest doses of each hepatotoxin and the livers of rats
administered with each vehicle (n=5).
At the end of each experiment, the rats were anesthetized and
sacrificed by pneumothorax and the liver and blood samples were
collected. The correct establishment of the acute hepatotoxicity
models by each toxin was confirmed by the determination of
plasma hepatotoxicity markers and histopathological examination.
The plasma alanine aminotransferase and aspartate aminotrans-
ferase levels were assessed using commercial kits (Roche
Diagnostics, GmbH, D- 68298, Mannheim, Germany) and a
Roche-Hitachi Modular Autoanalyzer (Roche Diagnostics). The
histological evaluation was performed using haematoxylin and
eosin liver-stained sections and light microscopy.
RNA purification. The total RNA from the livers of the
vehicle- and hepatotoxin-treated rats was isolated using the
TRIzol reagent (Invitrogen, San Diego, CA, USA), according to
the instructions of the manufacturer. Five pieces of different parts
of the liver were used in each case. The homogenization of the
samples was performed with a tissue-grinding tube and pestle,
using 1 ml of TRIzol reagent per 10 mg of liver tissue. The RNA
concentration and purity were determined measuring the
absorbance at 260 and 280 nm using a NanoVue UV
spectrophotometer (GE Healthcare, Piscataway, NJ, USA). The
RNA integrity was assessed by the 18S and 28S band intensity
ratio after 1.5% agarose gel electrophoresis visualized by ethidium
bromide staining. The RNA was stored at 270uC for future use.
Only those samples with a 260/280 ratio of approximately 2 (1.9
to 2.2) and a 28S/18S ratio $1.8 were used.
Candidate reference genes and primer design
Four microRNAs (miR-16, miR-103, miR-191 and miR-Let7a)
and three small RNA genes (5S, U6 and RNU48) were selected as
candidate RGs for the normalization of the microRNA RT-qPCR
data. Additionally, eight putative RGs were selected for the
normalization of our mRNA RT-qPCR expression studies: seven
mRNAs (ALB, ACTB, B2M, CYCA, GAPDH, HPRT1 and SDHA)
and one ribosomal RNA (18S). The primer sequences of the
candidate RGs, with their corresponding bibliographic reference
and amplicon sizes, are listed in Table 2. The NCBI (National
Center for Biotechnology Information [http://www.ncbi.nlm.nih.
gov]) and Ensembl (Ensembl Genome Browser [http://www.
ensembl.org/index.html]) databases were used to search for
available rat gene sequences to design primers using Primer3Plus
[51], taking into account the possible secondary structures of the
amplicon (Mfold) [52] and the amplicon specificity of the primers
(Blast) [53]. The reaction conditions were optimized by determin-
ing the optimal annealing temperature and primer concentration.
cDNA synthesis and real-time qPCR
The expression levels of microRNAs and small RNAs were
measured by Stem-Loop RT-qPCR [31] and the expression levels
of the mRNAs were determined by standard RT-qPCR [8,10].
Prior to the reverse transcription reaction, 1 mg of the total RNA
was treated with RQ1 RNase-free DNase (Promega, Madison,
WI, USA) according to the protocol of the manufacturer. The
first-strand cDNA synthesis was performed using SuperScript III
Reverse Transcriptase (Invitrogen) according to the instructions of
the manufacturer. For the cDNA synthesis of the microRNAs and
small RNAs, the reaction mixture included Stem-Loop Oligos
specific for each microRNA and specific primers for U6 and 5S.
The cDNA synthesis of the mRNAs was performed using both a
poly-dT primer and an 18S specific primer (see Table 2 for the
primer sequences). The reactions were incubated at 16uC for
30 min, 42uC for 30 min, 50uC for 60 min and 70uC for 15 min
in the case of the microRNA and small RNA retrotranscription.
The thermal protocol for mRNA was as follows: 50uC for 60 min
and 70uC for 15 min. The cDNA samples were diluted 1/50 for
the microRNA and small RNA determination or 1/20 for the
mRNA and 18S determination. The cDNA was stored at 220uC.
The PCR reactions were performed using an Mx3000P Real-
Time Thermocycler (Stratagene, La Jolla, CA, USA) using SYBR
Green I (Invitrogen) in a final volume of 20 ml. The reaction
mixture consisted of 2 mlo f1 0 6 PCR Buffer, 1.2 mlo f5 0m M
MgCl2, 0.4 ml of 10 mM GeneAmp dNTP Mix (Applied
Biosystems, Foster City, CA, USA), 0.8 mlo f1 0 6 SYBR Green
I (Invitrogen), 0.1 mlo f5U / ml Platinum Taq DNA Polymerase
(Invitrogen), 4 ml of 2.5 mM primer mix (forward and reverse
primers) and 5 ml of diluted cDNA. The PCR reactions were
initiated with a 1 min incubation at 95uC, followed by 40 cycles of
95uC for 15 s, 60uC for 30 s and 72uC for 40 s. A melting curve
was performed at the end of the PCR run over the range of 55–
95uC, increasing the temperature stepwise by 0.5uC every 2 s. The
baseline and Cq were automatically determined using MxPro
version 4.10 (Stratagene). No template controls were included for
each primer pair and each qPCR reaction was carried out in
duplicate. Gene-specific amplification was confirmed by a single
peak in the melting-curve analysis and a single band on a 2%
agarose gel stained with ethidium bromide. The sample maximi-
zation method criterion was used to establish the run layout.
A dilution series was created with random cDNA from our
sample group to construct standard curves for each primer pair.
The qPCR reactions were performed, as described above, in
duplicate. The mean Cq values for each serial dilution were
plotted against the logarithm of the cDNA dilution factor. The
amplification efficiency for each RG gene assay was calculated
from the expression [10
(1/-S)-1]6100%, where S represents the
slope of the linear regression [8,10].
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The Cq values were converted into RQ via the delta-Cq
method [54], incorporating the calculated amplification efficiency
for each primer pair [55]. The RQ values were calculated using
the average Cq of all of the samples studied as the calibrator [13].
For all of the statistical analyses, the expression data were
converted to logarithmic values to obtain symmetrical data. An
unpaired one-tailed or two-tailed t-test was used to compare two
separate sets of independent samples from the control and the
treated rats. The one-way-ANOVA test was used when more than
two groups were compared, followed by the Student-Newman–
Keuls test for multiple comparison. In all cases, p values of less
than 0.05 were considered statistically significant. Normality was
assessed using the Shapiro-Wilk test. The statistical procedures
were performed with the R program [http://www.R-project.org],
v2.13.1.
Candidate RGs that presented statistically significant differences
in their RQ values between the control and the treated groups
were confirmed in a new set of animals that were treated using the
same dosage (n=5 each group). Lastly, the RQ differences
between the control and the treated groups were normalized using
the RGs that were proposed afterwards. The NRQ belonging to
each group was obtained applying the normalization factor, which
was calculated as the geometric mean of the relative expression of
the RG selected.
To calculate the expression stability of the candidate RGs, the
following software was used: BestKeeper version 1 [14] [http://
gene-quantification.com/bestkeeper.html], geNorm version 3.5
[11] [http://medgen.ugent.be/,jvdesomp/genorm/] and Norm-
Finder version 0953 [15] [http://www.mdl.dk/
publicationsnormfinder.htm]. These freely available software
packages are application tools for Microsoft Excel. The stability
measurements produced by geNorm, NormFinder and Best-
Keeper were combined to establish a consensus rank of the genes
applying the RankAggreg package [http://cran.rproject.org/
web/packages/RankAggreg/index.html] of the R project [16].
The package RankAggreg has the ability to combine lists from
different sources, which may not otherwise be directly comparable,
as was performed in a previous work [50].
The simulated expression of a hypothetical gene of interest was
used to assess the efficiency of a chosen normalization method
(identity and number of genes selected). We used a modification of
the original strategy reported by Ponton et al. [17]. Different
normalization methods were evaluated, including a) individual
testing of all the RGs one by one or b) a combination of RGs
added stepwise according to the previously established stability
ranking. These methods were evaluated in two hypothetical
situations: with an increased and a decreased expression of the
hypothetical gene of interest in the treated groups with respect to
the control groups. The simulation of the expression of the
hypothetical gene of interest was performed by assigning the same
RQ value for all of the samples within each experimental group.
For the control samples, this value was set to 1 in both of the
hypothetical situations and the RQ values in the corresponding
treated group were adjusted to the minimum (or maximum) value
that produced a significant increase (or decrease) in the log-
transformed NRQ between the groups using the t-test (p=0.05).
Lastly, we calculated the ratio between the average NRQ value of
the gene of interest in the treated and the control groups, and this
value was defined as the NEI for every regulation condition
corresponding to a specific normalization method and hepatotox-
in. Therefore, in both cases, the NEI represents the x-fold up (or
down) change that reflects the minimum expression difference that
can be detected in the studied condition. The lower is the NEI
value, the higher is the efficiency of the normalization method
applied. Considering that the NEI is the NRQ value of a
hypothetical gene under specific conditions, we can estimate the
error associated with this determination through the error
propagation method reported by Hellemans et al. [13]. In this
report, the average NEI value (considering all of the hepatotoxins)
for situations of up- and down-regulation is used to evaluate each
normalization method and to establish the optimal number of RGs
to be used. A detailed description of the arithmetic procedure
through an example is offered in Data S3.
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